Lincocin

Country: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Lincomycin hydrochloride monohydrate equivalent to 250 mg lincomycin base;  

Disponibbli minn:

Pharmacia Limited Company trading as Pharmacia

INN (Isem Internazzjonali):

Lincomycin hydrochloride monohydrate (=250 mg lincomycin base)

Dożaġġ:

250 mg

Għamla farmaċewtika:

Capsule

Kompożizzjoni:

Active: Lincomycin hydrochloride monohydrate equivalent to 250 mg lincomycin base   Excipient: Lactose monohydrate Magnesium stearate Purified talc

Unitajiet fil-pakkett:

Bottle, plastic, 1x24, 24 capsules

Klassi:

Prescription

Tip ta 'preskrizzjoni:

Prescription

Manifatturat minn:

Pfizer Pharmaceuticals LLC

Indikazzjonijiet terapewtiċi:

indicated in the treatment of upper respiratory infections including tonsillitis, pharyngitis, otitis media, sinusitis, scarlet fever and as adjuvant therapy for diphtheria. Effectiveness in the treatment of mastoiditis would be anticipated.

Sommarju tal-prodott:

Package - Contents - Shelf Life: Bottle, plastic, - 24 capsules - 60 months from date of manufacture stored at or below 25°C - Bottle, plastic, - 100 capsules - 60 months from date of manufacture stored at or below 25°C

Data ta 'l-awtorizzazzjoni:

1969-12-31